News | August 26, 2024
Akums Q1 FY25 revenue up 5.1%
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Ayush is expanding beyond wellness to therapeutic wellness
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
GMM Pfaudler US completes acquisition of MixPro
Subscribe To Our Newsletter & Stay Updated
